Emma Kraynak
Physician Assistant · Uniontown, PANPI 1619215894
Payments from drug & device makers
Across 576 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$972
- Pfizer$864
- GSK$754
- AstraZeneca$734
- Lilly USA, LLC$661
- plus $4K from 37 others
What the payments were for
- Food & beverage$9,325100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,334 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 161 | $205,430 |
| EliquisApixaban | 132 | $127,222 |
| MounjaroTirzepatide | 78 | $98,741 |
| JardianceEmpagliflozin | 79 | $96,455 |
| RybelsusSemaglutide | 41 | $53,147 |
| XareltoRivaroxaban | 71 | $48,778 |
| TrulicityDulaglutide | 34 | $46,889 |
| Tresiba Flextouch U-200Insulin Degludec | 46 | $45,206 |
| FarxigaDapagliflozin Propanediol | 22 | $27,405 |
| Nurtec OdtRimegepant Sulfate | 16 | $23,239 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 15 | $21,387 |
| TradjentaLinagliptin | 15 | $20,408 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $19,954 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $18,587 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $17,635 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,071 | $258,577202 claims |
| PfizerEliquis, Nurtec Odt | $864 | $150,460148 claims |
| Lilly USA, LLCMounjaro, Trulicity | $661 | $145,630112 claims |
| Boehringer IngelheimJardiance, Tradjenta | $583 | $116,86294 claims |
| Johnson & JohnsonXarelto | $340 | $48,77871 claims |
| AstraZenecaFarxiga, Brilinta | $734 | $39,26240 claims |
| GSKBreo Ellipta, Trelegy Ellipta | $754 | $29,98242 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $189 | $21,38715 claims |
| MerckJanuvia | $84 | $17,53914 claims |
| Astellas Pharma US IncMyrbetriq | $85 | $10,25715 claims |
| Esperion Therapeutics, Inc.Nexletol | $27 | $8,30811 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $26 | $1,741216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Uniontown
- Erin CrownState College$1.5M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Alvin KingcadePhiladelphia$101K
- Jeffrey CameronWashington$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.